Cooper Companies, Inc. has announced a significant leadership transition following the resignation of its President and Chief Executive Officer, Albert G. White III. This change is poised to impact the company's strategic direction and operational performance as it seeks to enhance shareholder value.

On October 27, 2026, White stepped down from his executive roles and the Board of Directors, effective immediately. However, he will remain with the company as a strategic advisor until April 1, 2027, to assist in the transition of responsibilities.

Walter M. Rosebrough, Jr., an independent director of the Board, has been appointed as the Executive Chair on an interim basis. He will oversee day-to-day operations while the company searches for a permanent CEO. The Board has formed a CEO Search Committee, which includes Lawrence E. Kurzius, Cynthia L. Lucchese, and Teresa S. Madden, to facilitate this process.

Rosebrough brings extensive experience in the healthcare sector, having served as CEO of STERIS plc from 2007 to 2021. His leadership is expected to guide Cooper Companies through this transitional phase.

Background

Cooper Companies, Inc. operates within the ophthalmic goods industry, classified under SIC 3851. The company is listed on the Nasdaq under the ticker COO. It focuses on providing innovative medical devices and solutions in the vision care market.

Recent filings indicate that Cooper Companies has been active in corporate governance, with several updates and changes leading up to this significant transition.

What the Filing Says

The recent filing details White's resignation and Rosebrough's appointment. It states, "On October 27, 2026, Albert G. White III resigned from the Board of Directors and ceased serving in the offices of President and Chief Executive Officer of the Company." Additionally, it mentions that Rosebrough will take on the role of Executive Chair and oversee the search for a new CEO.

Impact

This leadership change may affect various stakeholders, including employees, investors, and customers. The transition aims to strengthen operational execution and improve business performance, which is crucial for maintaining Cooper's competitive edge in the ophthalmic goods sector.

What's Next

The search for a permanent CEO is currently underway, with support from the professional search firm Russell Reynolds. The company plans to provide updates on the CEO search and any further developments regarding the leadership transition.

Details were not available in the SEC filing regarding the specific timeline for the CEO search or additional changes to the Board.